| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |